Attempts by Oxford University researchers and AstraZeneca Plc to create a nasal-spray version of their jointly developed COVID-19 shot suffered a setback on Tuesday as initial testing on humans did not yield the desired protection.
The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, U.S., April 8, 2019. REUTERS/Brendan McDermidto create a nasal-spray version of their jointly developed COVID-19 shot suffered a setback on Tuesday as initial testing on humans did not yield the desired protection.
An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in the first of usually three phases of clinical testing, the University of Oxford said in a statement on Tuesday. Also, the immune response measured in the blood was weaker than that from a shot-in-the-arm vaccination.Researchers across the world have placed high hopes on nasal spray vaccines against the coronavirus because the method is believed to potentially prevent infection and not just disease as it may prompt an immune response directly in the airways, where the virus enters the body.Regulators in India and China have already cleared products that are administered through the airways.
India's health minister last month approved Bharat Biotech's COVID-19 nasal spray vaccine while China's CanSino Biologics Inc
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
History As It Happens: From Mussolini to MeloniThe Italian elections went in favor of a right-wing coalition led by Giorgia Meloni and her party, Brothers of Italy. After winning only four percent of the vote in 2018, Brothers of Italy earned enough votes to lead what will be the most right-wing Italian government since 1945. In fact, Meloni's party has a historic connection to post-war fascists, and she praised Mussolini as a teenage neo-fascist activist. Does this mean fascism is on the march in Italy again? If not fascism, what is it? In this episode, Roger Griffin, a foremost expert on the history of fascism at Oxford Brookes University, explains why right-wing populism is winning at the ballot box not just in Italy but across much of Europe.
Weiterlesen »
History As It Happens: From Mussolini to MeloniThe Italian elections went in favor of a right-wing coalition led by Giorgia Meloni and her party, Brothers of Italy. After winning only four percent of the vote in 2018, Brothers of Italy earned enough votes to lead what will be the most right-wing Italian government since 1945. In fact, Meloni's party has a historic connection to post-war fascists, and she praised Mussolini as a teenage neo-fascist activist. Does this mean fascism is on the march in Italy again? If not fascism, what is it? In this episode, Roger Griffin, a foremost expert on the history of fascism at Oxford Brookes University, explains why right-wing populism is winning at the ballot box not just in Italy but across much of Europe.
Weiterlesen »
History As It Happens: From Mussolini to MeloniThe Italian elections went in favor of a right-wing coalition led by Giorgia Meloni and her party, Brothers of Italy. After winning only four percent of the vote in 2018, Brothers of Italy earned enough votes to lead what will be the most right-wing Italian government since 1945. In fact, Meloni's party has a historic connection to post-war fascists, and she praised Mussolini as a teenage neo-fascist activist. Does this mean fascism is on the march in Italy again? If not fascism, what is it? In this episode, Roger Griffin, a foremost expert on the history of fascism at Oxford Brookes University, explains why right-wing populism is winning at the ballot box not just in Italy but across much of Europe.
Weiterlesen »
Are Nasal Sprays the Future for the COVID Vaccine?Are nasal sprays the future of COVID-19 vaccines? That’s certainly the hope of many researchers working on new kinds of inoculation. Nasalvaccines were recently approved in China and India for use as a booster dose. MedTwitter
Weiterlesen »